The cardiomyopathies.
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage; D000328:Adult; D000686:Amyloidosis / Q000473:pathology / Q000503:physiopathology; D000792:Angiography; D002302:Cardiac Output; D009202:Cardiomyopathies / Q000145:classification / Q000473:pathology* / Q000503:physiopathology; D002395:Catecholamines / Q000378:metabolism; D004719:Endomyocardial Fibrosis / Q000473:pathology / Q000503:physiopathology; D006333:Heart Failure / Q000473:pathology / Q000503:physiopathology; D006801:Humans; D008297:Male; D011217:Practolol / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D013610:Tachycardia / Q000209:etiology; D013927:Thrombosis / Q000473:pathology
D000319:Adrenergic beta-Antagonists; D002395:Catecholamines; D011433:Propranolol; D011217:Practolol